Year-end Sale % OFF 
Abstract
A patient in Virginia, USA, who had previously undergone multiple kidney transplantations showed signs of Bordetella hinzii bacteremia and meningitis. This emerging pathogen has been increasingly identified as a clinically significant pathogen in immunosuppressed and, less frequently, immunocompetent patients. This patient was treated and recovered without further issue.
Highlights
A patient in Virginia, USA, who had previously undergone multiple kidney transplantations showed signs of Bordetella hinzii bacteremia and meningitis
B. hinzii has been implicated as the cause of a range of clinical symptoms, including bacteremia [1,2,3], pulmonary disease [4,5,6], endocarditis [7], chronic cholangitis [8], and soft tissue abscess [9,10]
We describe a case of meningitis in an immunocompromised patient that was caused by B. hinzii
Summary
A patient in Virginia, USA, who had previously undergone multiple kidney transplantations showed signs of Bordetella hinzii bacteremia and meningitis This emerging pathogen has been increasingly identified as a clinically significant pathogen in immunosuppressed and, less frequently, immunocompetent patients. His most recent transplant, which occurred 10 years before the illness documented in this study, was performed with thymoglobulin induction and had been maintained with an immunosuppressive regimen of tacrolimus (goal trough of 5–7 ng/mL at the time of this hospitalization), 180 mg mycophenolic acid (2×/d), and 10 mg prednisone (1×/d) His medical history was further notable for seizure disorder and an allergy to penicillin, which manifested as severe urticaria. He appeared stable in the emergency department; vital signs were temperature 37.5°C, pulse rate 90 bpm, respiratory rate 17 breaths/min, blood pressure 141/85 mm Hg, and oxyhemoglobin saturation 99% on room air. Ceftriaxone was rapidly replaced with 2 g meropenem given the Emerging Infectious Diseases www.cdc.gov/eid Vol 27, No 9, September 2021
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
